NsGene

About:

NsGene develops products for the treatment of neurological, alzheimer’s, and parkinson's disease and sensorineural hearing loss.

Website: http://nsgene.dk

Top Investors: Vaekstfonden, Karolinska, DKA Capital, LD Pensions, Neurosearch

Description:

NsGene is a Danish Biotech company located in the Medicon Valley region. The Company is committed to developing novel biological products for the treatment of neurological diseases and is focusing on multiple indications with high unmet needs, including Alzheimer's disease, epilepsy, neuropathic pain and Parkinson's disease.

Total Funding Amount:

$5.69M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ballerup, Hovedstaden, Denmark

Founded Date:

1999-01-01

Founders:

Lars Wahlberg

Number of Employees:

11-50

Last Funding Date:

2013-11-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai